RU2045955C1 - Method for treating adnexites - Google Patents
Method for treating adnexites Download PDFInfo
- Publication number
- RU2045955C1 RU2045955C1 SU5028941A RU2045955C1 RU 2045955 C1 RU2045955 C1 RU 2045955C1 SU 5028941 A SU5028941 A SU 5028941A RU 2045955 C1 RU2045955 C1 RU 2045955C1
- Authority
- RU
- Russia
- Prior art keywords
- herbs
- leaves
- leaf
- common
- flowers
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 8
- 240000006891 Artemisia vulgaris Species 0.000 claims abstract description 5
- 240000001432 Calendula officinalis Species 0.000 claims abstract description 5
- 240000006927 Foeniculum vulgare Species 0.000 claims abstract description 5
- 244000307700 Fragaria vesca Species 0.000 claims abstract description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 5
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 5
- 244000025221 Humulus lupulus Species 0.000 claims abstract description 5
- 235000017309 Hypericum perforatum Nutrition 0.000 claims abstract description 5
- 244000141009 Hypericum perforatum Species 0.000 claims abstract description 5
- 235000002598 Inula helenium Nutrition 0.000 claims abstract description 5
- 244000116484 Inula helenium Species 0.000 claims abstract description 5
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 5
- 235000009108 Urtica dioica Nutrition 0.000 claims abstract description 5
- 235000005881 Calendula officinalis Nutrition 0.000 claims abstract description 4
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 claims abstract description 4
- 244000077923 Vaccinium vitis idaea Species 0.000 claims abstract description 4
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims abstract description 3
- 244000274883 Urtica dioica Species 0.000 claims abstract description 3
- 239000001771 mentha piperita Substances 0.000 claims abstract description 3
- 235000008694 Humulus lupulus Nutrition 0.000 claims abstract 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims abstract 2
- 238000001802 infusion Methods 0.000 claims description 9
- 244000025254 Cannabis sativa Species 0.000 claims description 8
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 4
- 235000018185 Betula X alpestris Nutrition 0.000 claims description 4
- 235000018212 Betula X uliginosa Nutrition 0.000 claims description 4
- 235000017443 Hedysarum boreale Nutrition 0.000 claims description 4
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims description 4
- 244000246386 Mentha pulegium Species 0.000 claims description 4
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 4
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 4
- 235000001050 hortel pimenta Nutrition 0.000 claims description 4
- 235000016970 Fragaria moschata Nutrition 0.000 claims description 3
- 235000014828 Fragaria vesca ssp. americana Nutrition 0.000 claims description 3
- 235000012660 Fragaria virginiana Nutrition 0.000 claims description 3
- 229940070641 chamomile flowers Drugs 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 240000000073 Achillea millefolium Species 0.000 claims description 2
- 235000002176 Foeniculum vulgare var vulgare Nutrition 0.000 claims description 2
- 241001456088 Hesperocnide Species 0.000 claims description 2
- 235000009809 Humulus lupulus var lupuloides Nutrition 0.000 claims description 2
- 235000006878 Humulus lupulus var neomexicanus Nutrition 0.000 claims description 2
- 235000009800 Humulus lupulus var pubescens Nutrition 0.000 claims description 2
- 235000009808 Humulus lupulus var. lupulus Nutrition 0.000 claims description 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 claims description 2
- 206010049677 Salpingo-oophoritis Diseases 0.000 claims description 2
- 239000001269 achillea millefolium l. oil Substances 0.000 claims description 2
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 claims 1
- 235000016704 Achillea millefolium ssp. borealis Nutrition 0.000 claims 1
- 235000014418 Achillea millefolium var alpicola Nutrition 0.000 claims 1
- 235000013159 Achillea millefolium var arenicola Nutrition 0.000 claims 1
- 235000013169 Achillea millefolium var millefolium Nutrition 0.000 claims 1
- 235000013184 Achillea millefolium var puberula Nutrition 0.000 claims 1
- 235000003880 Calendula Nutrition 0.000 claims 1
- 240000003538 Chamaemelum nobile Species 0.000 claims 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims 1
- 238000011287 therapeutic dose Methods 0.000 claims 1
- 235000008216 herbs Nutrition 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 6
- 235000012054 meals Nutrition 0.000 abstract description 3
- 235000016623 Fragaria vesca Nutrition 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 229940098465 tincture Drugs 0.000 abstract 3
- 241000722941 Achillea Species 0.000 abstract 1
- 235000004355 Artemisia lactiflora Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 235000003932 Betula Nutrition 0.000 abstract 1
- 241000219429 Betula Species 0.000 abstract 1
- 244000042664 Matricaria chamomilla Species 0.000 abstract 1
- 241001479543 Mentha x piperita Species 0.000 abstract 1
- 244000292697 Polygonum aviculare Species 0.000 abstract 1
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 3
- 229940125723 sedative agent Drugs 0.000 description 3
- 239000000932 sedative agent Substances 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 2
- 229940030225 antihemorrhagics Drugs 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000002874 hemostatic agent Substances 0.000 description 2
- NXFQHRVNIOXGAQ-YCRREMRBSA-N nitrofurantoin Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)NC(=O)C1 NXFQHRVNIOXGAQ-YCRREMRBSA-N 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 229940090898 Desensitizer Drugs 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229940124575 antispasmodic agent Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- -1 painkillers Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Изобретение относится к медицине, а именно к гинекологии. The invention relates to medicine, namely to gynecology.
Известен способ лечения аднексита, который включает применение антибактериальных, антигистаминных, дезинтоксикационных, симптоматических средств и витаминов. Помимо основных противовоспалительных средств, также применяют болеутоляющие, рассасывающие препараты, биостимуляторы, физиотерапевтические процедуры и гинекологический массаж. Курс лечения проводят в течение 14 дней. A known method of treating adnexitis, which includes the use of antibacterial, antihistamines, detoxification, symptomatic agents and vitamins. In addition to the main anti-inflammatory drugs, painkillers, absorbable drugs, biostimulants, physiotherapeutic procedures and gynecological massage are also used. The course of treatment is carried out for 14 days.
Однако применение антибиотиков приводит к токсико-аллергическим проявлениям их действия, большое количество лекарственных препаратов снижает напряженность иммунитета, развивается витаминная недостаточность и как следствие побочные осложнения, например кандидомикозы. However, the use of antibiotics leads to toxic-allergic manifestations of their action, a large number of drugs reduces immunity, vitamin deficiency develops and, as a result, side effects, such as candidomycosis.
Цель изобретения уменьшение лекарственной нагрузки и предотвращение осложнений. The purpose of the invention is the reduction of drug load and the prevention of complications.
Способ осуществляют следующим образом. Больной назначают курс лечения, включающий внутримышечное введение антибиотика по 1 мл два раза в день, фурадонин по 1 таблетке четыре раза в день, витамины В1, В6 по 1 мл внутримышечно, электрофорез с сульфатом цинка. С первого дня лечения дополнительно назначают настой травы полыни обыкновенной, травы горца птичьего, травы зверобоя продырявленного, травы тысячелистника обыкновенного, листа земляники лесной, листа березы бородавчатой, листа мяты перечной, листа брусники обыкновенной, корневищ с корнями девясила высокого, корня солодки голой, соплодий хмеля обыкновенного, цветков календулы лекарственной, цветков ромашки аптечной, плодов фенхеля обыкновенного, листа крапивы двудомной при следующем содержании компонентов смеси, 100 г/л настоя:
Трава полыни обыкновенной 9-11
Трава горца птичьего 9-11
Трава зверобоя продырявленного 9-11
Трава тысячелистника
обыкновенного 4-5
Лист земляники лесной 9-11
Лист березы бородавчатой 4-5
Лист мяты перечной 4-5
Лист брусники обыкновенной 4-5
Лист крапивы двудомной 9-11
Корневища с корнями девясила
высокого 4-5
Корень солодки голой 4-5
Соплодия хмеля обыкновенного 9-11
Цветки календулы лекарственной 9-11
Цветки ромашки аптечной 4-5
Плоды фенхеля обыкновенного 4-5
Настой готовят согласно требованиям ГФ-XI издания. 10,0 г измельченного до частиц размером не более 5 мм (листья, трава) и не более 3 мм (корневища, корни) лекарственного сырья помещают в эмалированную заранее прогретую в течение 15 мин на кипящей водяной бане инфундирку, заливают 100 г воды комнатной температуры и нагревают на кипящей водяной бане при частом помешивании в течение 15 мин. Затем инфундирку снимают с водяной бани, охлаждают при комнатной температуре не менее 45 мин, после чего процеживают, отжимая остаток растительного сырья, и доводят водой до 100 мл. Настой применяют перорально в дозах 30-60 мл на прием 3-5 раз в день за 15 мин до еды в тепло виде. Курс лечения проводят в течение 10-14 дней.The method is as follows. The patient is prescribed a course of treatment, including intramuscular administration of an antibiotic 1 ml twice a day, furadonin 1 tablet four times a day, vitamins B 1 , B 6 1 ml intramuscularly, electrophoresis with zinc sulfate. From the first day of treatment, an infusion of grass of common wormwood, grass of mountaineer bird, grass of St. John's wort, grass of yarrow, leaf of wild strawberry, leaf of warty birch leaf, leaf of peppermint, leaf of lingonberry ordinary, rhizomes with elecampane roots, licorice root, and fruit fruit is additionally prescribed. common hop, calendula officinalis flowers, pharmacy chamomile flowers, common fennel fruits, dioica nettle leaf with the following content of mixture components, 100 g / l of infusion:
Common wormwood herb 9-11
Highlander's Grass 9-11
Hypericum perforatum 9-11
Yarrow herb
ordinary 4-5
Strawberry leaf 9-11
Warty birch leaf 4-5
Peppermint Leaf 4-5
Lingonberry leaf 4-5
Stinging nettle leaf 9-11
Rhizomes with elecampane roots
high 4-5
Licorice root naked 4-5
Collopion of ordinary hop 9-11
Calendula officinalis flowers 9-11
Chamomile flowers pharmacy 4-5
Fennel fruits 4-5
The infusion is prepared according to the requirements of the GF-XI edition. 10.0 g crushed to a particle size of not more than 5 mm (leaves, grass) and not more than 3 mm (rhizomes, roots) of the medicinal raw material are placed in an enamelled infundirka preheated for 15 minutes in a boiling water bath, and 100 g of room temperature water is poured and heated in a boiling water bath with frequent stirring for 15 minutes Then the tunic is removed from the water bath, cooled at room temperature for at least 45 minutes, after which it is filtered, squeezing the remainder of the plant material, and adjusted to 100 ml with water. The infusion is used orally in doses of 30-60 ml per reception 3-5 times a day 15 minutes before meals in a warm form. The course of treatment is carried out for 10-14 days.
П р и м е р. Больная А. (история болезни N 3939) поступила в клинику с диагнозом: сальпингоофорит в стадии обострения. Назначают лечение: гентамицина сульфат 4% 1 мл два раза в день в/м; фурадонин по 1 таблетке четыре раза в день; витамины В1, В6 по 1 мл 5%-ного раствора в/м; электрофорез с сульфатом цинка N 10. С первого для лечения назначают настой из сбора трав в дозах по 60 мл 3 раза в день за 15 мин до еды. На пятый день исчезла боль, общее состояние больной улучшилось, появился аппетит, улучшился сон, наблюдалось значительное уменьшение воспалительного экссудата. Отменены антибиотики. Выписана в удовлетворительном состоянии, без осложнений
Пролечено в стационаре 126 пациенток с воспалительными заболеваниями матки и придатков в возрасте от 22 до 40 лет, с давностью заболевания от 2 до 10 лет. Больные были разделены на две группы. Контрольной группе назначили традиционное лечение: антибиотики, сульфаниламиды, болеутоляющие, седативные, смазмолитические, гемостатические средства, биостимуляторы, электрофорез. Опытной группе назначили комплексное лечение, включающее антибиотики, сульфаниламиды, витамины, электрофорез. С первого дня лечения дополнительно ввели в курс лечения настой из сбора трав: трижды в день больные получали по 60 мл внутрь. На 5-6 день в опытной группе у больных исчезли боли (без назначения седативных и обезболивающих средств). В эти же сроки отмечалось значительное уменьшение воспалительной экссудации (воспалительного инфильтрата), резкое снижение болезненности матки и придатков. Самочувствие больных резко улучшилось: восстанавливались сон, аппетит, повышался тонус организма. Снижалась впоследствии кровопотеря во время менструации (без применения сокращающих матку средств). В опытной группе наблюдался высокий терапевтический эффект без назначения болеутоляющих, седативных, спазмолитических, десенсибилизирующих, гемостатических средств.PRI me R. Patient A. (medical history N 3939) was admitted to the hospital with a diagnosis of salpingoophoritis in the acute stage. Prescribe treatment: gentamicin sulfate 4% 1 ml twice a day IM; furadonin 1 tablet four times a day; vitamins B 1 , B 6 , 1 ml of a 5% v / m solution; electrophoresis with zinc sulfate N 10. From the first for treatment, an infusion is prescribed from the collection of herbs in doses of 60 ml 3 times a day 15 minutes before meals. On the fifth day, the pain disappeared, the general condition of the patient improved, appetite appeared, sleep improved, and a significant decrease in inflammatory exudate was observed. Canceled antibiotics. Discharged in satisfactory condition, without complications
126 patients with inflammatory diseases of the uterus and appendages aged 22 to 40 years, with the disease duration from 2 to 10 years, were treated in a hospital. Patients were divided into two groups. The control group was prescribed the traditional treatment: antibiotics, sulfonamides, painkillers, sedatives, antioxidants, hemostatic agents, biostimulants, electrophoresis. The experimental group was prescribed complex treatment, including antibiotics, sulfonamides, vitamins, electrophoresis. From the first day of treatment, an infusion of herbs was added to the course of treatment: three times a day, patients received 60 ml orally. On days 5-6 in the experimental group, the pain disappeared from the patients (without prescribing sedatives and painkillers). At the same time, there was a significant decrease in inflammatory exudation (inflammatory infiltrate), a sharp decrease in soreness of the uterus and appendages. The well-being of the patients improved dramatically: sleep, appetite were restored, and the body's tone increased. Subsequently, blood loss during menstruation decreased (without the use of uterus-reducing drugs). In the experimental group, a high therapeutic effect was observed without the appointment of painkillers, sedatives, antispasmodics, desensitizers, hemostatic agents.
Claims (1)
Трава полыни обыкновенной 9 11
Трава горца птичьего 9 11
Трава зверобоя продырявленного 9 11
Трава тысячелистника обыкновенного 4 5
Лист земляники лесной 9 11
Лист березы бородавчатой 4 5
Лист крапивы двудомной 9 11
Лист мяты перечной 4 5
Лист брусники обыкновенной 4 5
Корневище с корнями девясила высокого 4 5
Корень солодки голой 4 5
Соплодия хмеля обыкновенного 9 11
Цветки календулы лекарственной 9 11
Цветки ромашки аптечной 4 5
Плоды фенхеля обыкновенного 4 5
2. Способ по п.1, отличающийся тем, что настой принимают по 60 мл три раза в день в течение 14 дней.1. A METHOD FOR TREATING ADNEXITIS, including the introduction of antibacterial agents and vitamins in therapeutic doses, characterized in that it is additionally administered with an infusion of common wormwood grass, bird highlander, Hypericum perforatum, common yarrow, wild strawberry leaves, warty birch leaves, peppermint, peppermint, peppermint with the roots of elecampane, licorice root, hops common fruit, medicinal calendula flowers, pharmacy chamomile, common fennel fruits, dicotyledonous nettle minutes with the following ratio of components, 100 g / l of infusion:
Common wormwood herb 9 11
Highlander's Grass 9 11
Hypericum perforatum 9 11
Yarrow herb 4 5
Leaf of wild strawberry 9 11
Warty birch leaf 4 5
Stinging nettle leaf 9 11
Peppermint leaf 4 5
Lingonberry leaf 4 5
Rhizome with the roots of elecampane high 4 5
Licorice root naked 4 5
Seedlings of common hop 9 11
Calendula officinalis flowers 9 11
Chamomile flowers pharmacy 4 5
Fennel ordinary 4 5
2. The method according to claim 1, characterized in that the infusion is taken in 60 ml three times a day for 14 days.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU5028941 RU2045955C1 (en) | 1992-02-24 | 1992-02-24 | Method for treating adnexites |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU5028941 RU2045955C1 (en) | 1992-02-24 | 1992-02-24 | Method for treating adnexites |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2045955C1 true RU2045955C1 (en) | 1995-10-20 |
Family
ID=21597698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU5028941 RU2045955C1 (en) | 1992-02-24 | 1992-02-24 | Method for treating adnexites |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2045955C1 (en) |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7195785B2 (en) * | 2001-06-20 | 2007-03-27 | Metaproteomics, Llc | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| US7270835B2 (en) | 2001-06-20 | 2007-09-18 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| RU2379048C1 (en) * | 2008-11-11 | 2010-01-20 | Мария Львовна Поспелова | Herbal tea for treating female sterility caused by anovulation |
| US7722903B2 (en) | 2001-06-20 | 2010-05-25 | Metaproteomics, Llc | Modulation of inflammation by hops fractions and derivatives |
| US7790205B2 (en) | 2002-10-21 | 2010-09-07 | Metaproteomics, Llc | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
| US7807203B2 (en) | 2001-06-20 | 2010-10-05 | Metaprotemics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
| US7811610B2 (en) | 2003-05-22 | 2010-10-12 | Metaproteomics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
| US7901713B2 (en) | 2001-06-20 | 2011-03-08 | Metaproteomics, Llc | Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops |
| US7914831B2 (en) | 2004-02-27 | 2011-03-29 | Metaproteomics, Llc | Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| WO2011068438A2 (en) | 2009-12-02 | 2011-06-09 | Общество С Ограниченной Ответственностью "Парафарм" | Agent for the treatment and prevention of diseases of the male urogenital system |
| US8158160B2 (en) | 2001-11-13 | 2012-04-17 | Eric Hauser Kuhrts | Anti-inflammatory cyclooxygenase inhibitors |
| US8168234B2 (en) | 2001-06-20 | 2012-05-01 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| US8206753B2 (en) | 2001-06-20 | 2012-06-26 | Metaproteomics, Llc | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
| US8241674B2 (en) | 2007-05-11 | 2012-08-14 | Metaproteomics, Llc | Methods and compositions for heavy metal detoxification |
| US8263139B2 (en) | 2005-08-09 | 2012-09-11 | Metaproteonics, Llc | Protein kinase modulation by hops and Acacia products |
| US8486457B2 (en) | 2002-10-21 | 2013-07-16 | Metaproteomics, Llc. | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| US8815306B2 (en) | 2007-03-19 | 2014-08-26 | Metaproteomics, Llc | Methods and compositions for promoting bone and joint health |
| WO2017007347A1 (en) * | 2015-07-08 | 2017-01-12 | Politechnika Wrocławska | A method of producing a plant preparation from a cone hops, knotweed and cranberry, pharmaceutical compositions containing such compounds and their usage |
-
1992
- 1992-02-24 RU SU5028941 patent/RU2045955C1/en active
Non-Patent Citations (1)
| Title |
|---|
| Соальский Я.П. и Иванюта Л.И. Воспалительные заболевания женских половых органов. Киев, 1975, с.104-148. * |
Cited By (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7815944B2 (en) | 2001-06-20 | 2010-10-19 | Metaproteomics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity |
| US7195785B2 (en) * | 2001-06-20 | 2007-03-27 | Metaproteomics, Llc | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| US7332185B2 (en) * | 2001-06-20 | 2008-02-19 | Metaproteomics, Llc | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| US7431948B2 (en) | 2001-06-20 | 2008-10-07 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| US8206753B2 (en) | 2001-06-20 | 2012-06-26 | Metaproteomics, Llc | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
| US7722903B2 (en) | 2001-06-20 | 2010-05-25 | Metaproteomics, Llc | Modulation of inflammation by hops fractions and derivatives |
| US8168234B2 (en) | 2001-06-20 | 2012-05-01 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| US7794757B2 (en) | 2001-06-20 | 2010-09-14 | Metaproteomics, Llc | Modulation of inflammation by hops fractions and derivatives |
| US7807203B2 (en) | 2001-06-20 | 2010-10-05 | Metaprotemics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
| US7901713B2 (en) | 2001-06-20 | 2011-03-08 | Metaproteomics, Llc | Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops |
| US7270835B2 (en) | 2001-06-20 | 2007-09-18 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| US7820206B2 (en) | 2001-06-20 | 2010-10-26 | Metaproteomics, Llc | Modulation of inflammation by hops fractions and derivatives |
| US8557306B2 (en) | 2001-06-20 | 2013-10-15 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| US7919125B2 (en) * | 2001-06-20 | 2011-04-05 | Metaproteomics, Llc | Modulation of inflammation by hops fractions and derivatives |
| US8609154B2 (en) | 2001-11-13 | 2013-12-17 | Metaproteomics, Llc | Anti-inflammatory cyclooxygenase inhibitors |
| US8158160B2 (en) | 2001-11-13 | 2012-04-17 | Eric Hauser Kuhrts | Anti-inflammatory cyclooxygenase inhibitors |
| US8846115B2 (en) | 2001-11-13 | 2014-09-30 | Metaproteomics, Inc. | Anti-inflammatory cyclooxygenase inhibitors |
| US8257754B2 (en) | 2002-10-21 | 2012-09-04 | Metaproteomics, Llc | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
| US8142819B2 (en) | 2002-10-21 | 2012-03-27 | Metaproteomics, Llc | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
| US7790205B2 (en) | 2002-10-21 | 2010-09-07 | Metaproteomics, Llc | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
| US8486457B2 (en) | 2002-10-21 | 2013-07-16 | Metaproteomics, Llc. | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| US7811610B2 (en) | 2003-05-22 | 2010-10-12 | Metaproteomics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
| US8092846B2 (en) | 2004-02-27 | 2012-01-10 | Metaproteomics, Llc | Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| US8193201B2 (en) | 2004-02-27 | 2012-06-05 | Metaproteomics, Llc | Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| US7914831B2 (en) | 2004-02-27 | 2011-03-29 | Metaproteomics, Llc | Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| US8263139B2 (en) | 2005-08-09 | 2012-09-11 | Metaproteonics, Llc | Protein kinase modulation by hops and Acacia products |
| US8815306B2 (en) | 2007-03-19 | 2014-08-26 | Metaproteomics, Llc | Methods and compositions for promoting bone and joint health |
| US8241674B2 (en) | 2007-05-11 | 2012-08-14 | Metaproteomics, Llc | Methods and compositions for heavy metal detoxification |
| US8475850B2 (en) | 2007-05-11 | 2013-07-02 | Metaproteomics, Llc | Methods and compositions for heavy metal detoxification |
| RU2379048C1 (en) * | 2008-11-11 | 2010-01-20 | Мария Львовна Поспелова | Herbal tea for treating female sterility caused by anovulation |
| WO2011068438A2 (en) | 2009-12-02 | 2011-06-09 | Общество С Ограниченной Ответственностью "Парафарм" | Agent for the treatment and prevention of diseases of the male urogenital system |
| WO2017007347A1 (en) * | 2015-07-08 | 2017-01-12 | Politechnika Wrocławska | A method of producing a plant preparation from a cone hops, knotweed and cranberry, pharmaceutical compositions containing such compounds and their usage |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2045955C1 (en) | Method for treating adnexites | |
| RU2044547C1 (en) | Composition for prevention and treatment of malignant tumors | |
| RU2190419C1 (en) | Medicinal vegetable species "fitomaks" | |
| CN101732521A (en) | Medicinal composition for treating fracture and preparation method thereof | |
| CN101919927B (en) | Spray for promoting scald healing | |
| RU2160596C1 (en) | Medicinal plants species possessing antiviral, antimicrobial and immunomodulation activity | |
| CN109432203B (en) | Pharmaceutical composition and traditional Chinese medicine raw material composition for treating non-lactation mastitis | |
| CN111297965A (en) | Traditional Chinese medicine composition for treating chronic nephritis | |
| CN110652544A (en) | Pharmaceutical composition for treating rhinitis and preparation method thereof | |
| RU99106367A (en) | PHYTOCOMPLEX FOR PREVENTION AND TREATMENT OF ONCOLOGIC PATIENTS AND METHOD OF PREVENTION AND TREATMENT OF ONCOLOGIC PATIENTS | |
| CN104825828A (en) | Medicinal paste with stomach warming and conditioning functions for external application | |
| CN104873911B (en) | A kind of pyemic traditional Chinese medicine for oral administration of auxiliary treatment | |
| CN110251564B (en) | A kind of external medicine for treating gouty arthritis and preparation method thereof | |
| CN102688368B (en) | Traditional Chinese medicine for treating trauma hemostasis or telephium | |
| RU2132198C1 (en) | Method of treatment of chronic diseases of hepatobiliary system with allergic component | |
| CN1233398C (en) | Medicine for treating stomatocase | |
| CN101181551B (en) | Externally used unction for curing hemorrhoid | |
| CN1030184A (en) | The manufacture method of anti-inflammation medicine | |
| CN1057926C (en) | Medicinal composition for curing gastrointestinal disease | |
| CN119113075A (en) | A kind of patch for treating oral ulcer and preparation method thereof | |
| CN1228324A (en) | Traditional Chinese medicinal plaster-Baiqigao for curing rheumatism, sciatica and traumatic injury | |
| CN114432412A (en) | A Chinese medicinal composition for treating fracture, and its preparation method | |
| CN103083552B (en) | Pills for treating neurodermatitis | |
| CN110694038A (en) | External traditional Chinese medicine composition for treating cholecystitis | |
| CN1098917A (en) | Eczema pellet |